Reduction of serum uric acid by hormone replacement therapy in postmenopausal women with hyperuricaemia

H Sumino; S Ichikawa; T Kanda; T Nakamura; T Sakamaki

doi:10.1016/S0140-6736(99)92381-4

Reduction of serum uric acid by hormone replacement therapy in postmenopausal women with hyperuricaemia

Lancet. 1999 Aug 21;354(9179):650. doi: 10.1016/S0140-6736(99)92381-4.

Authors

H Sumino, S Ichikawa, T Kanda, T Nakamura, T Sakamaki

PMID: 10466673
DOI: 10.1016/S0140-6736(99)92381-4

Abstract

Reduction of serum uric acid by hormone replacement therapy in postmenopausal women with hyperuricaemia is one of the cardiovascular protective mechanisms by which hormone replacement therapy reduces the risk of cardiovascular disease.

Publication types

Letter

MeSH terms

Cardiovascular Diseases / prevention & control
Estrogen Replacement Therapy*
Female
Humans
Middle Aged
Postmenopause / blood*
Uric Acid / blood*

Substances

Uric Acid